Core Scientific director buys 6,000 shares

Core Scientific, Inc. (CORZ) director Elizabeth Crain purchased Core Scientific common stock in the open market.

Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) director Elizabeth Crain purchased Core Scientific common stock in the open market. She bought 6,000 shares of common stock on 2026-08-20 at a weighted average price of $18.3324 per share, in multiple trades between $18.27 and $18.345. Following this transaction, she directly holds 71,348 shares of Core Scientific common stock.

Insider Trade Summary

Net Buyer: 6,000 shares

Net Buy 1 txn

Insider CRAIN ELIZABETH

Role Director

Bought 6,000 shs ($110K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	6,000	$18.3324	$110K

Holdings After Transaction: Common Stock — 71,348 shares (Direct)

Footnotes (1)

1. F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Key Figures

Shares purchased: 6,000 shares of Common Stock Weighted average purchase price: $18.3324 per share Trade price range: $18.27 to $18.345 per share +1 more

4 metrics

Shares purchased 6,000 shares of Common Stock Open-market purchase on 2026-08-20 by director Elizabeth Crain

Weighted average purchase price $18.3324 per share Average price for the 6,000 shares bought on 2026-08-20

Trade price range $18.27 to $18.345 per share Price range of multiple transactions comprising the 6,000-share purchase

Shares owned after transaction 71,348 shares Direct ownership by Elizabeth Crain following the reported purchase

Key Terms

weighted average price, Common Stock, Reporting Person

3 terms

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Reporting Person regulatory

"The Reporting Person undertakes to provide to the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CORZ director Elizabeth Crain report?

Elizabeth Crain reported an open-market purchase of 6,000 shares of Core Scientific common stock on 2026-08-20 at a weighted average price of $18.3324 per share, with individual trade prices ranging from $18.27 to $18.345.

How many CORZ shares does Elizabeth Crain own after this Form 4 transaction?

After the reported transaction, Elizabeth Crain directly owns 71,348 shares of Core Scientific common stock. This figure reflects her holdings immediately following the 6,000-share open-market purchase on 2026-08-20.

What price did Elizabeth Crain pay for the CORZ shares she purchased?

She paid a weighted average price of $18.3324 per share for the 6,000 Core Scientific shares. According to the disclosure, the shares were bought in multiple trades at prices ranging from $18.27 to $18.345, inclusive.

Was Elizabeth Crain’s CORZ stock purchase made in multiple trades?

Yes. The filing states the 6,000 shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, resulting in a weighted average price of $18.3324 per share.

Is Elizabeth Crain a director or officer of Core Scientific (CORZ)?

Elizabeth Crain is reported as a director of Core Scientific, Inc. She is not identified as an officer or ten percent owner in this Form 4, but she directly holds 71,348 shares after the reported purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:12 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CRAIN ELIZABETH

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2026		P		6,000	A	$18.3324(1)	71,348	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

	/s/ Todd DuChene, as Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)